PRKACB Antikörper
Kurzübersicht für PRKACB Antikörper (ABIN7674433)
Target
Alle PRKACB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- PRKACB-specifc antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- protein kinase, cAMP-dependent, catalytic, beta
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
-
Andere Bezeichnung
- PRKACB
-
Hintergrund
- CAMP-dependent protein kinase catalytic subunit beta (PKA C-beta)|PRKACB
-
Molekulargewicht
- 36 kDa
-
UniProt
- P22694
-
Pathways
- AMPK Signaling, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-